Six products.
One network.

The protocol depth your program needs without the hiring cycle. Four capability areas — Clinical Development, Biostatistics, Medical Writing, and Field Monitoring — matched by therapeutic area and phase. Every specialist has shipped a program like yours in the last twelve months; every engagement is scoped to the problem and not the calendar.

• Clinical Development & Operations
• Biostatistics & Programming
• Medical Writing (protocols, CSRs, IBs)
• Field Monitoring · 4,000+ CRAs
• Risk-based monitoring & RBM
• Study rescue & recovery operations

Ex-agency specialists on deck. Regulatory strategy, global submissions, CMC and quality, and agency liaison — from people who have been inside the room at FDA, EMA, PMDA, and MHRA. The ex-agency network is the part you cannot build in house and cannot hire on LinkedIn. It is the part that makes or breaks a filing.

• Regulatory strategy & filing plan
• IND / NDA / BLA submissions
• Agency liaison (ex-FDA/EMA/PMDA)
• CMC & quality
• Type B/C meeting leadership
• Response management & remediation

The value story that earns reimbursement. HEOR, HTA strategy across NICE, G-BA, HAS, and CADTH, real-world evidence, and value dossier development — for payers who do not take approval as proof. The specialists here have ranged across multiple markets in a single year, not a single market across their careers.

• HEOR and economic modeling
• HTA strategy (NICE, G-BA, HAS, CADTH)
• Real-world evidence & RWD
• Value dossier development
• PRO strategy & analysis
• Indirect comparisons & meta-analyses

Launch planning, medical affairs infrastructure, market access, and brand strategy from people who have been behind the counter on successful launches. The commercial readiness your approval depends on — not the commercial theory your approval suffers through.

• Launch planning & readiness
• Medical affairs infrastructure
• Market access & payer strategy
• Brand strategy & positioning
• KOL engagement plans
• Publication strategy

The boardroom-level brain you do not need full-time. Portfolio shaping, investor readiness, pipeline strategy, and commercial due diligence from operators who have run these functions inside. This is not a partnership at a consulting firm. It is a specialist on a scoped engagement.

• Portfolio shaping & prioritization
• Investor & board readiness
• Pipeline strategy & TPP development
• Commercial & scientific due diligence
• S-1 drafting support
• Pre-IPO advisory

When fractional becomes a full-time answer. Executive search for CMO, CSO, CDO roles, interim leadership seated in days, direct placement across functions, and board advisors. Drawn from the same pre-vetted network that powers every other product — the talent product is the only one where the engagement outlasts the specialist.

• Executive search (CMO, CSO, CDO)
• Interim leadership
• Direct placement
• Board & committee placement
• Head of function searches
• Scientific advisory